Cardiogen

Cardiogen

Peptide bioregulator developed by Vladimir Khavinson targeting heart tissue. Studied for organ-specific gene expression normalisation and age-related

Anti-AgingRecovery
● In Stock

Buy more, save more

1+ vials
−5%
3+ vials
−10%
5+ vials
−20%
10+ vials

Total Price

$190

For research & laboratory use only. Not for human consumption.

Administration Route

Subcutaneous injection

Cardiac Peptide

Khavinson tetrapeptide targeting cardiomyocyte gene expression

Heart Muscle Ageing

Restores protein synthesis in aged cardiac muscle cells

Post-Ischaemic Recovery

Animal models show improved recovery after simulated heart attack

Effect Profile

Cellular Longevity

0%

Collagen Synthesis

0%

Oxidative Protection

0%

Energy Restoration

0%

Mechanism of Action

Cardiogen is a short peptide bioregulator from the Khavinson series, designed to act as a complementary DNA sequence that penetrates cell nuclei and binds to gene promoter regions controlling cardiac myocyte regulation, coronary artery function, and myocardial tissue maintenance. By interacting with nuclear chromatin, it normalises the expression of genes involved in cell cycle regulation and tissue homeostasis, correcting age-associated downregulation of maintenance programmes in the target tissue.

Scientific Research

1
Peptide regulation of aging in heart tissue and anti-aging bioregulators

Annals of the New York Academy of Sciences (2005)

Product FAQs

Related Products

Cart

Your cart is empty